Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03396848 | Sexual Health and Rehabilitation eClinic (SHAReClinic) | unknown | N/A | 65 | University Health Network, TorontoOTHER | 1 | Apr 14, 2021 | clinicaltrials |
| NCT03876912 | The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer(ADTPSMA2) | unknown | N/A | 35 | Turku University HospitalOTHER_GOV | 1 | Apr 13, 2021 | clinicaltrials |
| NCT03770351 | Early Prostate Cancer: Predicting Treatment Response | unknown | — | 693 | University of California, IrvineOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT04839055 | The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC(CoA-CRPC) | unknown | Phase 1 / Phase 2 | 50 | Jiangnan UniversityOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT04836949 | Verification of Shear Wave Elastography for DEtection of Prostate Cancer | unknown | N/A | 170 | Yonsei UniversityOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04825002 | Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker Sensor | unknown | N/A | 800 | Asan Medical CenterOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT00653848 | Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy(AdRad) | unknown | Phase 3 | 378 | Scandinavian Prostate Cancer GroupNETWORK | 1 | Mar 25, 2021 | clinicaltrials |
| NCT04783636 | To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers | unknown | Phase 1 | 40 | Peptron, Inc.INDUSTRY | 0 | Mar 17, 2021 | clinicaltrials |
| NCT04803188 | Prostate Cancer Secondary Screening in Sapienza and Policlinico Umberto I(ProSa-I) | unknown | N/A | 710 | University of Roma La SapienzaOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04792138 | Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.(Histo-MRI) | unknown | — | 300 | University College, LondonOTHER | 1 | Mar 10, 2021 | clinicaltrials |
| NCT02623647 | A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate Cancer(eHYPO) | unknown | N/A | 150 | Regina Elena Cancer InstituteOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT03520478 | A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer | unknown | Phase 3 | 654 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 4 | Mar 2, 2021 | clinicaltrials |
| NCT04774133 | The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients. | unknown | N/A | 50 | Regina Elena Cancer InstituteOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT03064282 | Prostatic Hyperplasia Treatment and Cancer Prevention | unknown | Early Phase 1 | 40 | Manchanda Medical ClinicOTHER | 0 | Feb 25, 2021 | clinicaltrials |
| NCT02944201 | Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate | unknown | Phase 2 | 22 | Montefiore Medical CenterOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT00955435 | Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15 | unknown | — | 60 | Cancer Trials IrelandNETWORK | 1 | Feb 18, 2021 | clinicaltrials |
| NCT02895854 | LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients(BRAVEROBO) | unknown | N/A | 44 | Kuopio University HospitalOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT04746300 | imPlementing ROutine Molecular Characterization in Patients With Metastatic Castration Resistant ProstaTe Cancer by NGS(PROMPT) | unknown | — | 400 | Radboud University Medical CenterOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04736108 | Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate | unknown | Phase 2 | 50 | West China HospitalOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT03457805 | Prostatic Artery Embolization in Advanced Prostate Cancer | unknown | N/A | 20 | Dominik AbtOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT04017104 | Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging | unknown | — | 60 | British Columbia Cancer AgencyOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT00667888 | A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation | unknown | Phase 3 | 225 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT03432780 | Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer(QRT-SOGUG) | unknown | Phase 2 | 134 | Spanish Oncology Genito-Urinary GroupOTHER | 0 | Jan 22, 2021 | clinicaltrials |
| NCT04699344 | A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma Diagnosis | unknown | — | 500 | Qilu Hospital of Shandong UniversityOTHER | 1 | Jan 7, 2021 | clinicaltrials |
| NCT04622761 | Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome(CHROME) | unknown | Phase 2 | 120 | The Clatterbridge Cancer Centre NHS Foundation TrustOTHER | 0 | Jan 5, 2021 | clinicaltrials |
| NCT04642833 | Prostate Cancer in Renal Transplants Recipients(RENPRO) | unknown | — | 30 | University of FlorenceOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT01835977 | Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer | unknown | Phase 2 | 106 | Clinical Research Office of the Endourological SocietyOTHER | 0 | Dec 16, 2020 | clinicaltrials |
| NCT02255890 | Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device | unknown | — | 361 | Clinical Research Office of the Endourological SocietyOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT00303784 | Prostate Adenocarcinoma TransCutaneous Hormones(PATCH) | unknown | Phase 3 | 2,200 | University College, LondonOTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT01505075 | Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer(pHART8) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT01953055 | SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)(SATURN) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT02031328 | Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer(2STAR) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT02911636 | 5 Fractions of Pelvic SABR With Intra Prostatic SABR(5STAR) | unknown | N/A | 30 | Andrew LoblawOTHER | 0 | Nov 24, 2020 | clinicaltrials |
| NCT03307460 | uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness | unknown | Phase 2 | 52 | Rigshospitalet, DenmarkOTHER | 1 | Nov 23, 2020 | clinicaltrials |
| NCT04632251 | Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer(LPM-012) | unknown | N/A | 56 | Lightpoint Medical LimitedINDUSTRY | 4 | Nov 17, 2020 | clinicaltrials |
| NCT04586543 | Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma | unknown | Phase 2 | 110 | László MangelOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT04034953 | Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong | unknown | N/A | 10,000 | Chinese University of Hong KongOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT04577222 | The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical Prostatectomy | unknown | N/A | 60 | Rabin Medical CenterOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT04573179 | Effectiveness of 68Ga-PSMA PET/MRI for Improving the Detection of csPCa in Lesions With PI-RADS Score 3 | unknown | — | 60 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Oct 5, 2020 | clinicaltrials |
| NCT04567875 | Evaluation of Cardiotoxicity and Hypertension in Patients With Non Metastatic Castration Resistant Prostatic Carcinoma(Apa-CARDIO1) | unknown | — | 54 | Ospedale Andrea Tortora di PaganiNETWORK | 1 | Sep 29, 2020 | clinicaltrials |
| NCT04462926 | Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed(PSMA-PROSTAPET) | unknown | N/A | 100 | Azienda Ospedaliero-Universitaria di ModenaOTHER | 1 | Sep 17, 2020 | clinicaltrials |
| NCT04523896 | HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer(BRAchySABR) | unknown | Phase 2 | 50 | David BüchserOTHER_GOV | 1 | Aug 24, 2020 | clinicaltrials |
| NCT02282137 | 68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer(PSMA) | unknown | Phase 2 | 208 | Ebrahim DelpassandOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT04507698 | INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate Cancer(INTERVAL) | unknown | N/A | 80 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Aug 11, 2020 | clinicaltrials |
| NCT03212456 | Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia | unknown | N/A | 146 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Jul 29, 2020 | clinicaltrials |
| NCT03960112 | Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference(NPV-MRI-02) | unknown | N/A | 150 | Institut Paoli-CalmettesOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT04489745 | Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer | unknown | Phase 2 | 72 | VA Greater Los Angeles Healthcare SystemFED | 0 | Jul 28, 2020 | clinicaltrials |
| NCT04486937 | SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation(mCRPC) | unknown | Phase 1 / Phase 2 | 90 | Jiangxi Qingfeng Pharmaceutical Co. Ltd.INDUSTRY | 0 | Jul 27, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Apr 14, 2021source: clinicaltrials